Holland & Knight has advised Saol Therapeutics. Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, has entered into a definitive agreement through which funds managed by...
Saol Therapeutics Secures Up to $115 Million Milestone-Based Financing from Oaktree Capital Management
Thryv Holdings Sells Print Directories Business to Carolwood for $142 Million
Holland & Knight has advised Thryv Holdings Inc. in the sale of its print directories business to Carolwood L.P. Sheppard has represented Carolwood L.P. Thryv Holdings...
Thryv’s $435 Million Financing
Holland & Knight advised Thryv Inc. on the deal. Thryv Inc., a subsidiary of Thryv Holdings Inc. (Nasdaq: THRY), closed a $435 million financing transaction. The...
Bonsai Capital’s Acquisition of DC Logistics
Holland & Knight advised Bonsai Capital, LLC on the deal. Bonsai Capital, LLC, a search fund backed by a prominent group of family offices, announced the...
OnPeak Power’s Sale of Solar Projects
Holland & Knight advised OnPeak Power on the deal. OnPeak Power announced the sale of four U.S. solar projects totaling 1.1 GW to a new joint...